Announcements Trials
Browse Landscape

Status

Enrolling by invitation 1

Sponsor Class

OTHER_GOV 1

Study Type

Observational 1

Sponsor

Cancer Type

Other 1Gastrointestinal 1

Conditions

Stomach Neoplasms 1Pancreatic Neoplasms 1Obesity, Morbid 1Obesity 1Fistula 1Esophageal Neoplasms 1Duodenal Neoplasms 1Colonic Neoplasms 1Bile Duct Neoplasms 1Anastomotic Leak 1

Interventions

Oxaliplatin 64pembrolizumab 48Fluorouracil 44Capecitabine 38Nivolumab 33Leucovorin 32Paclitaxel 28Trastuzumab 19Docetaxel 18Cisplatin 18S 1 (combination) 16Bevacizumab 15Ramucirumab 13Irinotecan 13Drug Therapy 13tislelizumab 12Cyclophosphamide 12fludarabine 10Carboplatin 10Radiotherapy 9Magnetic Resonance Spectroscopy 9trastuzumab deruxtecan 8sintilimab 8Specimen Handling 8Biopsy 8atezolizumab 7Surgical Procedures, Operative 7Gemcitabine 7zolbetuximab 6durvalumab 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Stomach Neoplasms × Stents × 1 year × Clear all
NCT06862479 2026-05-06

ES-LCCE-UDFM

Unidade Local de Saúde Santa Maria

Enrolling by invitation
180 enrolled
GastrointestinalOther

Esophageal Neoplasms, Fistula, Obesity, Obesity, Morbid, Stomach Neoplasms, Anastomotic Leak

Data powered by HemOnc (CC BY 4.0) Colophon âš¡